VolitionRx Limited Gain (Loss) on Disposition of Assets
VolitionRx Limited (VNRX) reported Gain (Loss) on Disposition of Assets of -$330 for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2025-11-13
- VolitionRx Limited gain (loss) on disposition of assets for the quarter ending 2024-12-31 was -$38.00, a 154.29% decline year-over-year.
- VolitionRx Limited gain (loss) on disposition of assets for the quarter ending 2023-12-31 was $70.00.
- VolitionRx Limited gain (loss) on disposition of assets for the quarter ending 2020-12-31 was $283.00.
- VolitionRx Limited gain (loss) on disposition of assets for the quarter ending 2020-09-30 was -$200.39K.
- VolitionRx Limited gain (loss) on disposition of assets for fiscal 2024 was -$34.73K.
- VolitionRx Limited gain (loss) on disposition of assets for fiscal 2023 was -$15.84K.
- VolitionRx Limited gain (loss) on disposition of assets for fiscal 2020 was -$293.31K.
- VolitionRx Limited gain (loss) on disposition of assets for fiscal 2019 was $0.00.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$330.00 10-Q · filed 2025-11-13 | |||
| 2024-12-31 | -$38.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$34.73K 10-K · filed 2025-03-31 | ||
| 2024-09-30 | -$34.69K 10-Q · filed 2025-11-13 | |||
| 2023-12-31 | $70.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$15.84K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | -$15.91K 10-Q · filed 2024-11-14 | |||
| 2020-12-31 | $283.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | -$200.11K derived: sum of 2 quarters · filed 2021-03-22 | -$293.31K 10-K · filed 2021-03-22 | |
| 2020-09-30 | -$200.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$293.60K 10-Q · filed 2020-11-12 | ||
| 2020-06-30 | -$93.20K 10-Q · filed 2020-08-13 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $0.00 derived: sum of 2 quarters · filed 2021-03-22 | $0.00 10-K · filed 2021-03-22 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |